Related Experiment Video
Updated: May 15, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Adalimumab for the treatment of pityriasis rubra pilaris: a case report
Cindy Wassef1, Adriana Lombardi, Babar K Rao
1UMDNJ New Jersey Medical School, Newark, USA.
Cutis
|December 29, 2012
Abstract:
Pityriasis rubra pilaris (PRP) is a chronic papulosquamous eruption of the skin characterized by follicular hyperkeratosis, salmon pink scaly plaques with islands of unaffected skin, and palmoplantar keratoderma. Widely used oral systemic and topical treatments are not greatly effective. We present a 62-year-old man with PRP of 2 years' duration who used routine topical treatments, oral retinoids, and UV therapy without improvement, but his symptoms greatly improved with the initiation of adalimumab.
